|
MTFR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75231999999248E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.82529999999526E-05 |
| Normal-vs-Stage2 |
5.156500E-04 |
| Normal-vs-Stage3 |
2.454100E-02 |
| Normal-vs-Stage4 |
1.53182000000029E-05 |
| Stage1-vs-Stage2 |
6.055400E-01 |
| Stage1-vs-Stage3 |
9.257600E-01 |
| Stage1-vs-Stage4 |
2.309800E-01 |
| Stage2-vs-Stage3 |
6.927400E-01 |
| Stage2-vs-Stage4 |
6.624200E-01 |
| Stage3-vs-Stage4 |
4.564600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.70819999999861E-05 |
| Normal-vs-AfricanAmerican |
1.14020004549076E-09 |
| Normal-vs-Asian |
3.097600E-01 |
| Caucasian-vs-AfricanAmerican |
9.603800E-04 |
| Caucasian-vs-Asian |
7.188000E-01 |
| AfricanAmerican-vs-Asian |
3.962200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66306999999088E-05 |
| Normal-vs-Female |
1.081550E-03 |
| Male-vs-Female |
2.147000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32979999999339E-05 |
| Normal-vs-Age(41-60Yrs) |
1.69925999999876E-05 |
| Normal-vs-Age(61-80Yrs) |
6.427200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.475200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.547990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.658100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.220020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.622200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.302600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.249400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.469600E-02 |
| Normal-vs-Grade 2 |
7.999900E-03 |
| Normal-vs-Grade 3 |
2.74739999994722E-06 |
| Normal-vs-Grade 4 |
2.43829999524436E-08 |
| Grade 1-vs-Grade 2 |
4.626000E-01 |
| Grade 1-vs-Grade 3 |
9.344600E-01 |
| Grade 1-vs-Grade 4 |
3.087400E-01 |
| Grade 2-vs-Grade 3 |
2.857800E-01 |
| Grade 2-vs-Grade 4 |
8.060800E-03 |
| Grade 3-vs-Grade 4 |
2.513700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.467500E-02 |
| Normal-vs-ccB subtype |
2.827400E-04 |
| ccA subtype-vs-ccB subtype |
2.564300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.590000E-04 |
| Normal-vs-N1 |
1.016280E-02 |
| N0-vs-N1 |
6.799200E-01 |
|
|
